Stuart A Aaronson, M.D. - Publications

Affiliations: 
Icahn School of Medicine at Mount Sinai, New York, NY, United States 
Area:
Molecular Biology, Biochemistry
Website:
http://icahn.mssm.edu/profiles/stuart-a-aaronson

92 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Ahmed TA, Adamopoulos C, Karoulia Z, Wu X, Sachidanandam R, Aaronson SA, Poulikakos PI. SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-Dependent Tumors. Cell Reports. 26: 65-78.e5. PMID 30605687 DOI: 10.1016/j.celrep.2018.12.013  1
2017 Vijayakumar S, Liu G, Wen HC, Abu Y, Chong R, Nastri H, Bornstein GG, Pan ZQ, Aaronson SA. Extracellular LDLR repeats modulate Wnt signaling activity by promoting LRP6 receptor endocytosis mediated by the Itch E3 ubiquitin ligase. Genes & Cancer. 8: 613-627. PMID 28966723 DOI: 10.18632/genesandcancer.146  1
2017 Pappas K, Xu J, Zairis S, Resnick-Silverman L, Abate F, Steinbach N, Ozturk S, Saal LH, Su T, Cheung P, Schmidt H, Aaronson SA, Hibshoosh H, Manfredi JJ, Rabadan R, et al. p53 maintains baseline expression of multiple tumor suppressor genes. Molecular Cancer Research : McR. PMID 28483946 DOI: 10.1158/1541-7786.MCR-17-0089  1
2016 Guernet A, Aaronson SA, Anouar Y, Grumolato L. Modeling intratumor heterogeneity through CRISPR-barcodes. Molecular & Cellular Oncology. 3: e1227894. PMID 28090577 DOI: 10.1080/23723556.2016.1227894  0.08
2016 Muñoz-Fontela C, Mandinova A, Aaronson SA, Lee SW. Emerging roles of p53 and other tumour-suppressor genes in immune regulation. Nature Reviews. Immunology. PMID 27667712 DOI: 10.1038/nri.2016.99  1
2016 Guernet A, Mungamuri SK, Cartier D, Sachidanandam R, Jayaprakash A, Adriouch S, Vezain M, Charbonnier F, Rohkin G, Coutant S, Yao S, Ainani H, Alexandre D, Tournier I, Boyer O, ... Aaronson SA, et al. CRISPR-Barcoding for Intratumor Genetic Heterogeneity Modeling and Functional Analysis of Oncogenic Driver Mutations. Molecular Cell. PMID 27453044 DOI: 10.1016/j.molcel.2016.06.017  1
2016 Troilo A, Benson EK, Esposito D, Garibsingh RA, Reddy EP, Mungamuri SK, Aaronson SA. Angiomotin stabilization by tankyrase inhibitors antagonizes constitutive TEAD-dependent transcription and proliferation of human tumor cells with Hippo pathway core component mutations. Oncotarget. PMID 27144834 DOI: 10.18632/oncotarget.9117  1
2016 Mungamuri SK, Qiao RF, Yao S, Manfredi JJ, Gu W, Aaronson SA. USP7 Enforces Heterochromatinization of p53 Target Promoters by Protecting SUV39H1 from MDM2-Mediated Degradation. Cell Reports. PMID 26971997 DOI: 10.1016/j.celrep.2016.02.049  1
2015 Jayaprakash AD, Benson EK, Gone S, Liang R, Shim J, Lambertini L, Toloue MM, Wigler M, Aaronson SA, Sachidanandam R. Stable heteroplasmy at the single-cell level is facilitated by intercellular exchange of mtDNA. Nucleic Acids Research. 43: 2177-87. PMID 25653158 DOI: 10.1093/nar/gkv052  1
2015 Mungamuri SK, Wang S, Manfredi JJ, Gu W, Aaronson SA. Ash2L enables P53-dependent apoptosis by favoring stable transcription pre-initiation complex formation on its pro-apoptotic target promoters. Oncogene. 34: 2461-70. PMID 25023704 DOI: 10.1038/onc.2014.198  1
2014 Jeong MH, Ho SM, Vuong TA, Jo SB, Liu G, Aaronson SA, Leem YE, Kang JS. Cdo suppresses canonical Wnt signalling via interaction with Lrp6 thereby promoting neuronal differentiation. Nature Communications. 5: 5455. PMID 25406935 DOI: 10.1038/ncomms6455  1
2014 Liscio P, Carotti A, Asciutti S, Ferri M, Pires MM, Valloscuro S, Ziff J, Clark NR, Macchiarulo A, Aaronson SA, Pellicciari R, Camaioni E. Scaffold hopping approach on the route to selective tankyrase inhibitors. European Journal of Medicinal Chemistry. 87: 611-23. PMID 25299683 DOI: 10.1016/j.ejmech.2014.10.007  1
2014 Pires MM, Aaronson SA. Brachyury: a new player in promoting breast cancer aggressiveness. Journal of the National Cancer Institute. 106. PMID 24815862 DOI: 10.1093/jnci/dju094  1
2014 Liscio P, Carotti A, Asciutti S, Karlberg T, Bellocchi D, Llacuna L, Macchiarulo A, Aaronson SA, Schüler H, Pellicciari R, Camaioni E. Design, synthesis, crystallographic studies, and preliminary biological appraisal of new substituted triazolo[4,3-b]pyridazin-8-amine derivatives as tankyrase inhibitors. Journal of Medicinal Chemistry. 57: 2807-12. PMID 24527792 DOI: 10.1021/jm401356t  1
2014 Benson EK, Mungamuri SK, Attie O, Kracikova M, Sachidanandam R, Manfredi JJ, Aaronson SA. p53-dependent gene repression through p21 is mediated by recruitment of E2F4 repression complexes. Oncogene. 33: 3959-69. PMID 24096481 DOI: 10.1038/onc.2013.378  1
2013 Mungamuri SK, Murk W, Grumolato L, Bernstein E, Aaronson SA. Chromatin modifications sequentially enhance ErbB2 expression in ErbB2-positive breast cancers. Cell Reports. 5: 302-13. PMID 24120871 DOI: 10.1016/j.celrep.2013.09.009  1
2013 Hamard PJ, Barthelery N, Hogstad B, Mungamuri SK, Tonnessen CA, Carvajal LA, Senturk E, Gillespie V, Aaronson SA, Merad M, Manfredi JJ. The C terminus of p53 regulates gene expression by multiple mechanisms in a target- and tissue-specific manner in vivo. Genes & Development. 27: 1868-85. PMID 24013501 DOI: 10.1101/gad.224386.113  1
2013 Grumolato L, Liu G, Haremaki T, Mungamuri SK, Mong P, Akiri G, Lopez-Bergami P, Arita A, Anouar Y, Mlodzik M, Ronai ZA, Brody J, Weinstein DC, Aaronson SA. β-Catenin-independent activation of TCF1/LEF1 in human hematopoietic tumor cells through interaction with ATF2 transcription factors. Plos Genetics. 9: e1003603. PMID 23966864 DOI: 10.1371/journal.pgen.1003603  1
2013 Serysheva E, Berhane H, Grumolato L, Demir K, Balmer S, Bodak M, Boutros M, Aaronson S, Mlodzik M, Jenny A. Wnk kinases are positive regulators of canonical Wnt/β-catenin signalling. Embo Reports. 14: 718-25. PMID 23797875 DOI: 10.1038/embor.2013.88  1
2013 Kracikova M, Akiri G, George A, Sachidanandam R, Aaronson SA. A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis. Cell Death and Differentiation. 20: 576-88. PMID 23306555 DOI: 10.1038/cdd.2012.155  1
2013 Shapiro M, Akiri G, Chin C, Wisnivesky JP, Beasley MB, Weiser TS, Swanson SJ, Aaronson SA. Wnt pathway activation predicts increased risk of tumor recurrence in patients with stage I nonsmall cell lung cancer. Annals of Surgery. 257: 548-54. PMID 23011390 DOI: 10.1097/SLA.0b013e31826d81fd  1
2012 Brown-Endres L, Schoenfeld D, Tian F, Kim HG, Namba T, Muñoz-Fontela C, Mandinova A, Aaronson SA, Lee SW. Expression of the p53 target CDIP correlates with sensitivity to TNFα-induced apoptosis in cancer cells. Cancer Research. 72: 2373-82. PMID 22549949 DOI: 10.1158/0008-5472.CAN-11-3369  1
2012 Mungamuri SK, Benson EK, Wang S, Gu W, Lee SW, Aaronson SA. p53-mediated heterochromatin reorganization regulates its cell fate decisions. Nature Structural & Molecular Biology. 19: 478-84, S1. PMID 22466965 DOI: 10.1038/nsmb.2271  1
2011 Muñoz-Fontela C, Pazos M, Delgado I, Murk W, Mungamuri SK, Lee SW, García-Sastre A, Moran TM, Aaronson SA. p53 serves as a host antiviral factor that enhances innate and adaptive immune responses to influenza A virus. Journal of Immunology (Baltimore, Md. : 1950). 187: 6428-36. PMID 22105999 DOI: 10.4049/jimmunol.1101459  1
2011 Vijayakumar S, Liu G, Rus IA, Yao S, Chen Y, Akiri G, Grumolato L, Aaronson SA. High-frequency canonical Wnt activation in multiple sarcoma subtypes drives proliferation through a TCF/β-catenin target gene, CDC25A. Cancer Cell. 19: 601-12. PMID 21575861 DOI: 10.1016/j.ccr.2011.03.010  1
2010 Grumolato L, Liu G, Mong P, Mudbhary R, Biswas R, Arroyave R, Vijayakumar S, Economides AN, Aaronson SA. Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes & Development. 24: 2517-30. PMID 21078818 DOI: 10.1101/gad.1957710  1
2010 Singh J, Yanfeng WA, Grumolato L, Aaronson SA, Mlodzik M. Abelson family kinases regulate Frizzled planar cell polarity signaling via Dsh phosphorylation. Genes & Development. 24: 2157-68. PMID 20837657 DOI: 10.1101/gad.1961010  1
2010 Benson EK, Lee SW, Aaronson SA. Role of progerin-induced telomere dysfunction in HGPS premature cellular senescence. Journal of Cell Science. 123: 2605-12. PMID 20605919 DOI: 10.1242/jcs.067306  1
2009 Ide T, Brown-Endres L, Chu K, Ongusaha PP, Ohtsuka T, El-Deiry WS, Aaronson SA, Lee SW. GAMT, a p53-inducible modulator of apoptosis, is critical for the adaptive response to nutrient stress. Molecular Cell. 36: 379-92. PMID 19917247 DOI: 10.1016/j.molcel.2009.09.031  1
2009 Benson EK, Zhao B, Sassoon DA, Lee SW, Aaronson SA. Effects of p21 deletion in mouse models of premature aging. Cell Cycle (Georgetown, Tex.). 8: 2002-4. PMID 19535900  1
2009 Liu G, Vijayakumar S, Grumolato L, Arroyave R, Qiao H, Akiri G, Aaronson SA. Canonical Wnts function as potent regulators of osteogenesis by human mesenchymal stem cells. The Journal of Cell Biology. 185: 67-75. PMID 19349579 DOI: 10.1083/jcb.200810137  1
2009 Zhao B, Benson EK, Qiao R, Wang X, Kim S, Manfredi JJ, Lee SW, Aaronson SA. Cellular senescence and organismal ageing in the absence of p21(CIP1/WAF1) in ku80(-/-) mice. Embo Reports. 10: 71-8. PMID 19079133 DOI: 10.1038/embor.2008.220  1
2008 Das S, Boswell SA, Aaronson SA, Lee SW. P53 promoter selection: choosing between life and death. Cell Cycle (Georgetown, Tex.). 7: 154-7. PMID 18212532  1
2007 Das S, Raj L, Zhao B, Kimura Y, Bernstein A, Aaronson SA, Lee SW. Hzf Determines cell survival upon genotoxic stress by modulating p53 transactivation. Cell. 130: 624-37. PMID 17719541 DOI: 10.1016/j.cell.2007.06.013  1
2007 Liu XH, Kirschenbaum A, Yao S, Liu G, Aaronson SA, Levine AC. Androgen-induced Wnt signaling in preosteoblasts promotes the growth of MDA-PCa-2b human prostate cancer cells. Cancer Research. 67: 5747-53. PMID 17575141 DOI: 10.1158/0008-5472.CAN-07-0478  1
2006 Ongusaha PP, Kim HG, Boswell SA, Ridley AJ, Der CJ, Dotto GP, Kim YB, Aaronson SA, Lee SW. RhoE is a pro-survival p53 target gene that inhibits ROCK I-mediated apoptosis in response to genotoxic stress. Current Biology : Cb. 16: 2466-72. PMID 17174923 DOI: 10.1016/j.cub.2006.10.056  1
2005 Bernstein JL, Godbold JH, Raptis G, Watson MA, Levinson B, Aaronson SA, Fleming TP. Identification of mammaglobin as a novel serum marker for breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 6528-35. PMID 16166429 DOI: 10.1158/1078-0432.CCR-05-0415  1
2005 Hall CL, Bafico A, Dai J, Aaronson SA, Keller ET. Prostate cancer cells promote osteoblastic bone metastases through Wnts. Cancer Research. 65: 7554-60. PMID 16140917 DOI: 10.1158/0008-5472.CAN-05-1317  1
2005 Liu G, Bafico A, Aaronson SA. The mechanism of endogenous receptor activation functionally distinguishes prototype canonical and noncanonical Wnts. Molecular and Cellular Biology. 25: 3475-82. PMID 15831454 DOI: 10.1128/MCB.25.9.3475-3482.2005  1
2005 Manfredi JJ, Dong J, Liu WJ, Resnick-Silverman L, Qiao R, Chahinian P, Saric M, Gibbs AR, Phillips JI, Murray J, Axten CW, Nolan RP, Aaronson SA. Evidence against a role for SV40 in human mesothelioma. Cancer Research. 65: 2602-9. PMID 15805256 DOI: 10.1158/0008-5472.CAN-04-2461  1
2005 Aaronson S. Teaching resources. Growth factor and receptor tyrosine kinases. Science's Stke : Signal Transduction Knowledge Environment. 2005: tr6. PMID 15728427 DOI: 10.1126/stke.2722005tr6  1
2005 Ibrahimi OA, Yeh BK, Eliseenkova AV, Zhang F, Olsen SK, Igarashi M, Aaronson SA, Linhardt RJ, Mohammadi M. Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization. Molecular and Cellular Biology. 25: 671-84. PMID 15632068 DOI: 10.1128/MCB.25.2.671-684.2005  1
2004 Bafico A, Liu G, Goldin L, Harris V, Aaronson SA. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell. 6: 497-506. PMID 15542433 DOI: 10.1016/j.ccr.2004.09.032  1
2003 Liu G, Bafico A, Harris VK, Aaronson SA. A novel mechanism for Wnt activation of canonical signaling through the LRP6 receptor. Molecular and Cellular Biology. 23: 5825-35. PMID 12897152  1
2003 Ongusaha PP, Kim Ji, Fang L, Wong TW, Yancopoulos GD, Aaronson SA, Lee SW. p53 induction and activation of DDR1 kinase counteract p53-mediated apoptosis and influence p53 regulation through a positive feedback loop Embo Journal. 22: 1289-1301. PMID 12628922 DOI: 10.1093/emboj/cdg129  1
2003 Yeh BK, Igarashi M, Eliseenkova AV, Plotnikov AN, Sher I, Ron D, Aaronson SA, Mohammadi M. Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors. Proceedings of the National Academy of Sciences of the United States of America. 100: 2266-71. PMID 12591959 DOI: 10.1073/pnas.0436500100  1
2002 Han JA, Kim JI, Ongusaha PP, Hwang DH, Ballou LR, Mahale A, Aaronson SA, Lee SW. p53-mediated induction of Cox-2 counteracts p53- or genotoxic stress-induced apoptosis Embo Journal. 21: 5635-5644. PMID 12411481 DOI: 10.1093/emboj/cdf591  1
2002 Spiegelman VS, Tang W, Chan AM, Igarashi M, Aaronson SA, Sassoon DA, Katoh M, Slaga TJ, Fuchs SY. Induction of homologue of Slimb ubiquitin ligase receptor by mitogen signaling. The Journal of Biological Chemistry. 277: 36624-30. PMID 12151397 DOI: 10.1074/jbc.M204524200  1
2002 Macip S, Igarashi M, Fang L, Chen A, Pan ZQ, Lee SW, Aaronson SA. Inhibition of p21-mediated ROS accumulation can rescue p21-induced senescence. The Embo Journal. 21: 2180-8. PMID 11980715 DOI: 10.1093/emboj/21.9.2180  1
1995 Aaronson S. Lung cancer: emerging therapeutic approaches based on molecular genetics Mount Sinai Journal of Medicine. 62: 204-205. PMID 7616975  1
1993 Aaronson SA. Growing families of fibroblast growth factors and receptors Japanese Journal of Cancer Research : Gann. 84. PMID 8320162  1
1993 Aaronson SA. Ligands and receptors International Journal of Cancer. 53: 170-171.  1
1991 Kraus MH, Aaronson SA. Detection and isolation of novel protein-tyrosine kinase genes employing reduced stringency hybridization Methods in Enzymology. 200: 546-556. PMID 1835515 DOI: 10.1016/0076-6879(91)00170-2  1
1991 Aaronson SA. Influences of growth factors and their signaling pathways in malignancy Harvey Lectures. 87: 17-34. PMID 1670547  1
1991 Aaronson SA. Growth factors and cancer Science. 254: 1146-1153. PMID 1659742  1
1990 Aaronson SA. In the interest of clearer communication (IV) In Vitro Cellular and Developmental Biology - Animal. 26: 4.  1
1988 Tronick SR, Aaronson SA. Oncogenes, growth regulation, and cancer Advances in Second Messenger and Phosphoprotein Research. 21: 201-214. PMID 3137959  1
1986 Lacal JC, Aaronson SA. ras p21 deletion mutants and monoclonal antibodies as tools for localization of regions relevant to p21 function Proceedings of the National Academy of Sciences of the United States of America. 83: 5400-5404. PMID 2426696  1
1985 Aaronson SA, Tronick SR. The role of oncogenes in human neoplasia Important Advances in Oncology. 3-15. PMID 3916746  1
1985 Eva A, Aaronson SA. Isolation of a new human oncogene from a diffuse B-cell lymphoma Nature. 316: 273-275. PMID 3875039 DOI: 10.1038/316273a0  1
1985 Aaronson SA, Tronick SR. Transforming genes of human malignancies Carcinogenesis; a Comprehensive Survey. 10: 35-49. PMID 2998614  1
1985 Pierce JH, Aaronson SA. Myeloid cell transformation by ras-containing murine sarcoma viruses Molecular and Cellular Biology. 5: 667-674. PMID 2985965  1
1985 Weissman B, Aaronson SA. Members of the src and ras oncogene families supplant the epidermal growth factor requirement of BALB/MK-2 keratinocytes and induce distinct alterations in their terminal differentiation program Molecular and Cellular Biology. 5: 3386-3396. PMID 2427928  1
1983 Aaronson SA. Unique Aspects of the Interactions of Retroviruses with Vertebrate Cells: C. P. Rhoads Memorial Lecture Cancer Research. 43: 1-5. PMID 6847757  1
1983 Eva A, Aaronson SA. Frequent activation of c-kis as a transforming gene in fibrosarcomas induced by methylcholanthrene Science. 220: 955-956. PMID 6302839  1
1979 Canaani E, Aaronson SA. Restriction enzyme analysis of mouse cellular type C viral DNA: Emergence of new viral sequences in spontaneous AKR/J lymphomas Proceedings of the National Academy of Sciences of the United States of America. 76: 1677-1681. PMID 221902  1
1978 Barbacid M, Aaronson SA. Membrane properties of the gag gene-coded p15 protein of mouse type-C RNA tumor viruses. The Journal of Biological Chemistry. 253: 1408-14. PMID 627545  1
1978 Aaronson SA, Barbacid M. Origin and biological properties of a new BALB/c mouse sarcoma virus. Journal of Virology. 27: 366-73. PMID 80461  1
1976 Stephenson JR, Aaronson SA. Search for antigens and antibodies crossreactive with type C viruses of the woolly monkeys and gibbon ape in animal models and in humans. Proceedings of the National Academy of Sciences of the United States of America. 73: 1725-9. PMID 179097  1
1976 Stephenson JR, Aaronson SA. Induction of an endogenous B-tropic type C RNA virus from SWR/J mouse embryo cells in tissue culture. Virology. 70: 352-9. PMID 57668 DOI: 10.1016/0042-6822(76)90277-4  1
1975 Stephenson JR, Aaronson SA. Genetics of endogenous mouse C-type viruses. Bibliotheca Haematologica. 657-8. PMID 169833  1
1975 Greenberger JS, Aaronson SA. Cycloheximide induction of xenotropic type C virus from synchronized mouse cells: metabolic requirements for virus activation Journal of Virology. 15: 64-70. PMID 163347  1
1974 Stephenson JR, Anderson GR, Tronick SR, Aaronson SA. Evidence for genetic recombination between endogenous and exogenous mouse RNA type C viruses. Cell. 2: 87-94. PMID 4376054 DOI: 10.1016/0092-8674(74)90096-8  1
1974 Stephenson JR, Aaronson SA. Demonstration of a genetic factor influencing spontaneous release of a xenotropic virus of mouse cells. Proceedings of the National Academy of Sciences of the United States of America. 71: 4925-9. PMID 4373736  1
1974 Aaronson SA, Anderson GR, Dunn CY, Robbins KC. Induction of type C RNA virus by cycloheximide: increased expression of virus specific RNA Proceedings of the National Academy of Sciences of the United States of America. 71: 3941-3945. PMID 4372598  1
1974 Greenberger JS, Anderson GR, Aaronson SA. Transformation-Defective virus mutants in a class of morphologic revertants of sarcoma virus transformed nonproducer cells Cell. 2: 279-286. PMID 4370517 DOI: 10.1016/0092-8674(74)90022-1  1
1974 Greenberger JS, Aaronson SA. Morphologic revertants of murine sarcoma virus transformed nonproducer BALB/3T3: Selective techniques for isolation and biologic properties in vitro and in vivo Virology. 57: 339-346. PMID 4361451 DOI: 10.1016/0042-6822(74)90173-1  1
1974 Aaronson SA, Dunn CY. Endogenous C type viruses of BALB/c cells: Frequencies of spontaneous and chemical induction Journal of Virology. 13: 181-185. PMID 4359422  1
1974 Aaronson SA, Dunn CY. High frequency C type virus induction by inhibitors of protein synthesis Science. 183: 422-423. PMID 4358074  1
1973 Greenberger JS, Aaronson SA. In vivo inoculation of RNA C type viruses inducing regression of experimental solid tumors Journal of the National Cancer Institute. 51: 1935-1938. PMID 4358149  1
1973 Aaronson SA. Biologic characterization of mammalian cells transformed by a primate sarcoma virus Virology. 52: 562-567. PMID 4122326 DOI: 10.1016/0042-6822(73)90351-6  1
1972 Stephenson JR, Aaronson SA. A genetic locus for inducibility of C-type in BALB-c cells: the effect of a nonlinked regulatory gene on detection of virus after chemical activation. Proceedings of the National Academy of Sciences of the United States of America. 69: 2798-801. PMID 4344375  1
1972 Aaronson SA. Immunologic detection of C-type RNA viral reverse transcriptases National Cancer Institute Monograph. 35: 83-87. PMID 4121495  1
1972 Stephenson JR, Aaronson SA. Genetic factors influencing C-type RNA virus induction. The Journal of Experimental Medicine. 136: 175-84. PMID 4113509  1
1971 Aaronson S. Inhibition of Yeast Multiplication by Hypocholesteremic Compounds and its Annulment by Lipids Proceedings of the Society For Experimental Biology and Medicine. 136: 61-63. PMID 5540639 DOI: 10.3181/00379727-136-35192  1
1971 Aaronson SA. Chemical induction of focus-forming virus from nonproducer cells transformed by murine sarcoma virus Proceedings of the National Academy of Sciences of the United States of America. 68: 3069-3072. PMID 4332005  1
1971 Aaronson SA. Isolation of a rat-tropic helper virus from M-MSV-O stocks Virology. 44: 29-36. PMID 4328487 DOI: 10.1016/0042-6822(71)90149-8  1
1971 Aaronson SA. Common genetic alterations of RNA tumour viruses grown in human cells Nature. 230: 445-447. PMID 4324859 DOI: 10.1038/230445a0  1
1970 Aaronson SA. Susceptibility of human cell strains to transformation by simian virus 40 and simian virus 40 deoxyribonucleic acid Journal of Virology. 6: 470-475. PMID 5497893  1
1970 Aaronson SA. Effect of ultraviolet irradiation on the survival of simian virus 40 functions in human and mouse cells Journal of Virology. 6: 393-399. PMID 5497884  1
1966 Aaronson SA, Korner A, Munro AJ. Inhibition by soluble ribonucleic acid of stimulatory effect of liver template ribonucleic acid. The Biochemical Journal. 101: 448-53. PMID 5338167  0.12
1965 Aaronson SA, Natori Y, Tarver H. Effect of Estrogen on Uterine ATP Levels Proceedings of the Society For Experimental Biology and Medicine. 120: 9-10. PMID 5892462 DOI: 10.3181/00379727-120-30428  1
Show low-probability matches.